Safety and Efficacy of Sintilimab in Combination With Chemoradiothrapy Followed by D2 Surgical Resection in Patients With Advanced Gastric Cancer With Retroperitoneal Lymph Node Metastasis

NCT05002686 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Sintilimab
DRUG: Albumin-Paclitaxel
DRUG: Capecitabine
DRUG: Oxaliplatin
RADIATION: Radiation
PROCEDURE: Radical gastric cancer surgery

Sponsor

Ruijin Hospital